A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia

BACKGROUND: The real-world experience of Swiss chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) is largely unknown, in particular with regard to achievement of response per European Leukemia Net (ELN) criteria and adherence to ELN recommendations. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantoni, Nathan, Sommavilla, Roberto, Seitz, Patrick, Kulenkampff, Elisabeth, Kahn, Stefan, Lambert, Jean-François, Schmidt, Adrian, Zenhaeusern, Reinhard, Balabanov, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675134/
https://www.ncbi.nlm.nih.gov/pubmed/36402993
http://dx.doi.org/10.1186/s12885-022-10241-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675134/
https://www.ncbi.nlm.nih.gov/pubmed/36402993
http://dx.doi.org/10.1186/s12885-022-10241-y

Ejemplares similares